In this study, we explored the effect of circRNA Cdr1as on the cisplatin chemosensitivity of bladder cancer and demonstrate the related regulatory mechanism, that is, the novel Cdr1as/miR‐1270/APAF1 axis. Here, LINC00632 is linked to urinary bladder cancer.